Literature DB >> 8247190

Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

T Liberek1, N Topley, A Jörres, M M Petersen, G A Coles, G M Gahl, J D Williams.   

Abstract

In order to elucidate the mechanism of peritoneal dialysis fluid inhibition of cell functions, laboratory-prepared fluids were used to investigate the specific influences of low pH and high lactate concentration on neutrophil viability, phagocytosis, respiratory burst activation and leukotriene B4 (LTB4) generation. In the absence of any reduction of viability, respiratory burst activation, stimulated by serum-treated zymosan (STZ), was significantly inhibited by fluids of low pH containing high concentrations of sodium lactate. Neither low pH nor lactate concentration alone, however, caused significant suppression of this parameter of cell activation. Under the same conditions, the phagocytosis of STZ was partially inhibited in a lactate- and pH-dependent manner. In contrast, the generation of LTB4 in response to STZ was unaffected by pH and lactate concentration. The incubation of polymorphonuclear leukocytes (PMN) in fluids containing 35 mM lactate at pH 5.2 resulted in an immediate and profound lowering in intracellular pH ([pH]i) which was not observed in lactate-containing fluids at neutral pH or at low pH in the absence of lactate. We postulate that the critical lowering of [pH]i in PMN, caused by the combination of high lactate concentration and low pH of the dialysis fluids, is responsible for the observed inhibition of respiratory burst activation. It is also possible that under these conditions, the lactate ion acts as a proton carrier across the cell membrane following the [H+] gradient. The time course of this [pH]i change suggests that host defence mechanisms may be impaired following short-time exposure to unused dialysis fluid prior to its equilibration in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247190     DOI: 10.1159/000187485

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution.

Authors:  Chieko Hamada; Kazuho Honda; Kunio Kawanishi; Hirotaka Nakamoto; Yasuhiko Ito; Tsutomu Sakurada; Yudo Tanno; Toru Mizumasa; Masanobu Miyazaki; Misaki Moriishi; Masaaki Nakayama
Journal:  J Artif Organs       Date:  2015-02-14       Impact factor: 1.731

2.  The effect of peritoneal rest in combination therapy of peritoneal dialysis and hemodialysis: using the cultured human peritoneal mesothelial cell model.

Authors:  Tadashi Tomo; Eiji Okabe; Kazuhiro Matsuyama; Tomohiko Iwashita; Keiko Yufu; Masaru Nasu
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

3.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

4.  The pH dependence of NADPH oxidase in human eosinophils.

Authors:  Deri Morgan; Vladimir V Cherny; Ricardo Murphy; Ben Z Katz; Thomas E DeCoursey
Journal:  J Physiol       Date:  2005-09-29       Impact factor: 5.182

Review 5.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

6.  Peritoneal dialysis: from bench to bedside.

Authors:  Raymond T Krediet
Journal:  Clin Kidney J       Date:  2013-10-14

7.  The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.

Authors:  Cheuk-Chun Szeto; Bonnie C H Kwan; Kai-Ming Chow; Phyllis M S Cheng; Vickie W K Kwong; Agnes S M Choy; Man-Ching Law; Chi-Bon Leung; Philip K T Li
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

8.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10

Review 9.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

10.  BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].

Authors:  Barbara Nau; Claus P Schmitt; Margarida Almeida; Klaus Arbeiter; Gianluigi Ardissino; Klaus E Bonzel; Alberto Edefonti; Michel Fischbach; Karin Haluany; Joachim Misselwitz; Markus J Kemper; Kai Rönnholm; Simone Wygoda; Franz Schaefer
Journal:  BMC Nephrol       Date:  2004-10-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.